Biogen Pharmachem Reports Q2 Results with ₹25.73 Lakh Profit
Biogen Pharmachem Industries Ltd · Outcome · 03 Nov 2026, 8:42 pm
Biogen Pharmachem Reports Q2 Results with ₹25.73 Lakh Profit Biogen Pharmachem Industries posted a net profit of ₹25.73 lakh for the quarter ended 30th Sep'26, turning around from a net loss of ₹49.15 lakh in the year-ago period and up 16.2% QoQ from ₹22.14 lakh. Core operational revenue remained nil, with total income entirely driven by other income of ₹28.33 lakh versus negative ₹10.49 lakh YoY. Total expenses fell sharply to ₹2.61 lakh from ₹38.67 lakh YoY. For H1 ended 30th Sep'26, net profit reached ₹47.87 lakh compared to ₹85.33 lakh YoY.
Original exchange filing (PDF)
More announcements from Biogen Pharmachem Industries Ltd
- PFA · 03 Nov 2026
- PFA · 03 Nov 2026
- Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Pursuant to .... · 03 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd · 23 Oct 2026
- PFA · 30 Sept 2026
- PFA · 29 Sept 2026
- Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial .... · 04 Sept 2026
- PFA · 04 Sept 2026
